A dose escalation study of docetaxel plus capecitabine in combination with oxaliplatin in patients with advanced solid tumors-Reference-Cited by-同舟云学术

A dose escalation study of docetaxel plus capecitabine in combination with oxaliplatin in patients with advanced solid tumors

Published:2009-10-20 Issue:2 Volume:49 Page:245-251
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Amarantidis Kyriakos,Xenidis Nikolaos,Chelis Leonidas,Chiotis Anestis,Tentes Apostolos,Chatzaki Ekaterini,Kortsaris Alexandros,Polychronidis A.,Karakitsos Petros,Kakolyris Stylianos

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/02841860903253553

Reference26 articles.

1. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

2. Capecitabine: the new generation of fluoropyrimidines in colorectal cancer

3. Capecitabine

4. Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer

5. Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gender-dependent association of TYMS-TSER polymorphism with 5-fluorouracil or capecitabine-based chemotherapy toxicity;Pharmacogenomics;2021-07

2. Phase I/II trial of triplet regimen with docetaxel, oxaliplatin and capecitabine in advanced gastric and gastroesophageal cancers;Clinical Cancer Investigation Journal;2015

3. Docetaxel plus Oxaliplatin in Combination with Capecitabine as First-Line Treatment for Advanced Gastric Cancer;Oncology;2011